Periodic Reporting for period 1 - CYPNASH (Validation of a novel class of cyclophilin inhibitors for the treatment of non-alcoholic steatohepatitis)

The goal of the ERC Proof of Concept CYPNASH activity was to develop further a novel class of ‘trivector’ cyclophilin inhibitors that were discovered during the activities of the previously funded ERC Starting Grant EBDD. Such molecules may possess advantages over existing...